{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:34:04Z","timestamp":1792506844588,"version":"4.5.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T00:00:00Z","timestamp":1727136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008741","name":"European League Against Rheumatism","doi-asserted-by":"publisher","award":["QoC011"],"award-info":[{"award-number":["QoC011"]}],"id":[{"id":"10.13039\/501100008741","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1136\/ard-2024-225853","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T13:20:14Z","timestamp":1727184014000},"page":"1748-1761","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Systemic juvenile idiopathic arthritis and adult-onset Still's disease are the same disease: evidence from systematic reviews and meta-analyses informing the 2023 EULAR\/PReS recommendations for the diagnosis and management of Still's disease"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8098-8199","authenticated-orcid":false,"given":"Arianna","family":"De Matteis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9409-3329","authenticated-orcid":false,"given":"Sara","family":"Bindoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8749-8232","authenticated-orcid":false,"given":"Fabrizio","family":"De Benedetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4401-2551","authenticated-orcid":false,"given":"Loreto","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8845-4274","authenticated-orcid":false,"given":"Bruno","family":"Fautrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5244-7881","authenticated-orcid":false,"given":"St\u00e9phane","family":"Mitrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard-2024-225853_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/095952879708000106","article-title":"On a form of chronic joint disease in children","volume":"80","author":"Still","year":"1897","journal-title":"Med Chir Trans"},{"key":"10.1136\/ard-2024-225853_bib2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/ard.30.2.121","article-title":"Still's disease in the adult","volume":"30","author":"Bywaters","year":"1971","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-225853_bib3","first-page":"107","article-title":"Chronic arthritis in childhood","volume":"37","author":"Oration","year":"1977","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-225853_bib4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.revmed.2019.06.001","article-title":"Le temps EST Venu de R\u00e9concilier L'Arthrite Juv\u00e9nile Idiopathique Syst\u00e9mique et La Maladie de still de L'Adulte","volume":"40","author":"Jamilloux","year":"2019","journal-title":"La Revue de M\u00e9decine Interne"},{"key":"10.1136\/ard-2024-225853_bib5","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41584-018-0081-x","article-title":"Mechanisms, biomarkers and targets for adult-onset still's disease","volume":"14","author":"Feist","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1136\/ard-2024-225853_bib6","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.pcl.2018.04.005","article-title":"Systemic juvenile idiopathic arthritis","volume":"65","author":"Lee","year":"2018","journal-title":"Pediatr Clin North Am"},{"key":"10.1136\/ard-2024-225853_bib7","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1136\/annrheumdis-2019-215211","article-title":"Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis","volume":"78","author":"Minoia","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-225853_bib8","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the hscore, a score for the diagnosis of reactive hemophagocytic syndrome: score for reactive hemophagocytic syndrome","volume":"66","author":"Fardet","year":"2014","journal-title":"Arthritis & Rheumatology"},{"key":"10.1136\/ard-2024-225853_bib9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/annrheumdis-2015-208982","volume":"75","author":"Ravelli","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-225853_bib10","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3899\/jrheum.141261","article-title":"Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"42","author":"Minoia","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2024-225853_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s12026-014-8561-9","article-title":"Pathogenesis of adult-onset still's disease: new insights from the juvenile counterpart","volume":"61","author":"Jamilloux","year":"2015","journal-title":"Immunol Res"},{"key":"10.1136\/ard-2024-225853_bib12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.clim.2016.05.010","article-title":"Cytokine profile in adult-onset still's disease: comparison with systemic juvenile idiopathic arthritis","volume":"169","author":"Inoue","year":"2016","journal-title":"Clin Immunol"},{"key":"10.1136\/ard-2024-225853_bib13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12969-015-0047-3","article-title":"Gene-expression analysis of adult-onset still's disease and systemic juvenile idiopathic arthritis is consistent with a continuum of a single disease entity","volume":"13","author":"Nirmala","year":"2015","journal-title":"Pediatr Rheumatol"},{"key":"10.1136\/ard-2024-225853_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1136\/ard-2024-225853_bib15","first-page":"390","article-title":"International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision","volume":"31","author":"Petty","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2024-225853_bib16","first-page":"712","article-title":"Criteria for the classification of juvenile rheumatoid arthritis","volume":"23","author":"Brewer","year":"1972","journal-title":"Bull Rheumatol Dis"},{"key":"10.1136\/ard-2024-225853_bib17","first-page":"1991","article-title":"Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997","volume":"25","author":"Petty","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2024-225853_bib18","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3899\/jrheum.180168","article-title":"Toward new classification criteria for juvenile idiopathic arthritis: first steps pediatric rheumatology International trials organization International consensus","volume":"46","author":"Martini","year":"2019","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2024-225853_bib19","first-page":"424","article-title":"Preliminary criteria for classification of adult still's disease","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2024-225853_bib20","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00005792-200205000-00003","article-title":"Proposal for a new set of classification criteria for adult-onset still disease","volume":"81","author":"Fautrel","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"10.1136\/ard-2024-225853_bib21","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/art.1780190216","article-title":"Carpal arthritis with Ankylosis in late onset still's disease","volume":"19","author":"Medsger","year":"1976","journal-title":"Arthritis & Rheumatism"},{"key":"10.1136\/ard-2024-225853_bib22","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00005792-199103000-00004","article-title":"Adult still's disease: manifestations, disease course, and outcome in 62 patients","volume":"70","author":"Pouchot","year":"1991","journal-title":"Medicine (Baltimore)"},{"key":"10.1136\/ard-2024-225853_bib23","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.3899\/jrheum.100247","article-title":"Clinical manifestations but not cytokine profiles differentiate adult-onset still's disease and sepsis","volume":"37","author":"Rau","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2024-225853_bib24","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jclinepi.2011.11.014","article-title":"Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of Interrater agreement","volume":"65","author":"Hoy","year":"2012","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1136\/ard-2024-225853_bib25","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I","article-title":"Interval estimation for the difference between independent proportions: comparison of eleven methods","volume":"17","author":"Newcombe","year":"1998","journal-title":"Statist Med"},{"key":"10.1136\/ard-2024-225853_bib26","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1136\/ard-2024-225853_bib27","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard-2024-225853_bib28","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s41927-019-0053-z","article-title":"Comparative study of Interleukin-18 (IL-18) serum levels in adult onset still's disease (AOSD) and systemic onset juvenile idiopathic arthritis (sJIA) and its use as a biomarker for diagnosis and evaluation of disease activity","volume":"3","author":"Kudela","year":"2019","journal-title":"BMC Rheumatol"},{"key":"10.1136\/ard-2024-225853_bib29","doi-asserted-by":"crossref","first-page":"6703","DOI":"10.3390\/jcm11226703","article-title":"The spectrum of still's disease: a comparative analysis of phenotypic forms in a cohort of 238 patients","volume":"11","author":"Neau","year":"2022","journal-title":"J Clin Med"},{"key":"10.1136\/ard-2024-225853_bib30","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/rheumatology\/34.5.429","article-title":"Adult onset still's disease in northern India: comparison with juvenile onset still's disease","volume":"34","author":"Uppal","year":"1995","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard-2024-225853_bib31","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10067-005-0138-5","article-title":"A multicenter study of patients with adult-onset still's disease compared with systemic juvenile idiopathic arthritis","volume":"25","author":"Pay","year":"2006","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard-2024-225853_bib32","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s100670050030","article-title":"Different articular outcomes of still's disease in Chinese children and adults","volume":"19","author":"Lin","year":"2000","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard-2024-225853_bib33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/annrheumdis-2019-216030","article-title":"Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis","volume":"79","author":"Lee","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-225853_bib34","article-title":"Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset still's disease. analysis of the multicentre Gruppo Italiano Di Ricerca in reumatologia clinica E Sperimentale (GIRRCS) cohort","volume":"15","author":"Di","year":"2020","journal-title":"PLoS One"},{"key":"10.1136\/ard-2024-225853_bib35","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/acr2.11048","article-title":"Ferritin to erythrocyte sedimentation rate ratio: simple measure to identify macrophage activation syndrome in systemic juvenile idiopathic arthritis","volume":"1","author":"Eloseily","year":"2019","journal-title":"ACR Open Rheumatology"},{"key":"10.1136\/ard-2024-225853_bib36","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.semarthrit.2014.09.004","article-title":"Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis","volume":"44","author":"Kostik","year":"2015","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1136\/ard-2024-225853_bib37","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3390\/jcm11010206","article-title":"Detection and prediction of macrophage activation syndrome in still's disease","volume":"11","author":"Javaux","year":"2021","journal-title":"J Clin Med"},{"key":"10.1136\/ard-2024-225853_bib38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12519-019-00256-0","article-title":"Clinical and laboratory features, treatment, and outcomes of macrophage activation syndrome in 80 children: a multi-center study in China","volume":"16","author":"Zou","year":"2020","journal-title":"World J Pediatr"},{"key":"10.1136\/ard-2024-225853_bib39","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jpeds.2012.11.081","article-title":"Differentiating macrophage activation syndrome in systemic juvenile idiopathic arthritis from other forms of hemophagocytic lymphohistiocytosis","volume":"162","author":"Lehmberg","year":"2013","journal-title":"J Pediatr"},{"key":"10.1136\/ard-2024-225853_bib40","doi-asserted-by":"crossref","first-page":"e563","DOI":"10.1016\/S2665-9913(21)00115-6","article-title":"Definition and validation of serum biomarkers for optimal differentiation of hyperferritinaemic cytokine storm conditions in children: a retrospective cohort study","volume":"3","author":"Kessel","year":"2021","journal-title":"The Lancet Rheumatology"},{"key":"10.1136\/ard-2024-225853_bib41","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1182\/blood.2021013549","article-title":"Expansion of Cd4Dimcd8+ T cells characterizes macrophage activation syndrome and other secondary HLH","volume":"140","author":"De Matteis","year":"2022","journal-title":"Blood"},{"key":"10.1136\/ard-2024-225853_bib42","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/s41390-020-0843-4","article-title":"Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis during tocilizumab therapy","volume":"88","author":"Irabu","year":"2020","journal-title":"Pediatr Res"},{"key":"10.1136\/ard-2024-225853_bib43","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jbspin.2017.08.001","article-title":"New classification for juvenile idiopathic arthritis: is the tower of babel falling","volume":"85","author":"Belot","year":"2018","journal-title":"Joint Bone Spine"},{"key":"10.1136\/ard-2024-225853_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.25904","article-title":"Pediatric hematology normal ranges derived from pediatric primary care patients","volume":"95","author":"Staffa","year":"2020","journal-title":"American J Hematol"},{"key":"10.1136\/ard-2024-225853_bib45","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3899\/jrheum.120386","article-title":"Patients with very early-onset systemic juvenile idiopathic arthritis exhibit more inflammatory features and a worse outcome","volume":"40","author":"Russo","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2024-225853_bib46","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1080\/03009740701340339","article-title":"Why can we no longer find juvenile idiopathic arthritis\u2010associated amyloidosis in childhood or in adolescence in Finland","volume":"36","author":"Immonen","year":"2007","journal-title":"Scand J Rheumatol"},{"key":"10.1136\/ard-2024-225853_bib47","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.semarthrit.2019.08.005","article-title":"AA Amyloidosis secondary to adult onset still's disease: about 19 cases","volume":"50","author":"Delplanque","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard-2024-225853_bib48","series-title":"Textbook of Autoinflammation","first-page":"587","author":"Nigrovic","year":"2019"},{"key":"10.1136\/ard-2024-225853_bib49","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.revmed.2014.10.365","article-title":"Donn\u00e9es Actualis\u00e9es sur La Physiopathologie, LES Ph\u00e9notypes et LES Traitements de la Maladie de still de L'Adulte","volume":"36","author":"Gerfaud-Valentin","year":"2015","journal-title":"La Revue de M\u00e9decine Interne"},{"key":"10.1136\/ard-2024-225853_bib50","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MD.0000000000000021","article-title":"Adult-onset still disease: manifestations, treatment, outcome, and Prognostic factors in 57 patients","volume":"93","author":"Gerfaud-Valentin","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1136\/ard-2024-225853_bib51","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1093\/rheumatology\/keu257","article-title":"What does an adult rheumatologist need to know about juvenile idiopathic arthritis?","volume":"53","author":"Coulson","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard-2024-225853_bib52","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1546-0096-10-40","article-title":"\u201cApplication of the yamaguchi criteria for classification of \u201csuspected\u201d systemic juvenile idiopathic arthritis (sJIA)\u201d","volume":"10","author":"Kumar","year":"2012","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1136\/ard-2024-225853_bib53","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3899\/jrheum.161286","article-title":"Application of the 2016 EULAR\/ACR\/PRINTO classification criteria for macrophage activation syndrome in patients with adult-onset still disease","volume":"44","author":"Ahn","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2024-225853_bib54","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00296-018-4114-1","article-title":"Are the 2016 EULAR\/ACR\/PRINTO classification criteria for macrophage activation syndrome applicable to patients with adult-onset still's disease?","volume":"39","author":"Tada","year":"2019","journal-title":"Rheumatol Int"},{"key":"10.1136\/ard-2024-225853_bib55","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00296-020-04750-x","article-title":"Performances of the \u2018MS-score\u2019 and \u2018Hscore\u2019 in the diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis patients","volume":"41","author":"Sag","year":"2021","journal-title":"Rheumatol Int"},{"key":"10.1136\/ard-2024-225853_bib56","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1136\/ard-2023-224123","article-title":"The 2022 EULAR\/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis\/macrophage activation syndrome (HLH\/MAS)","volume":"82","author":"Shakoory","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-225853_bib57","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1182\/blood-2017-12-820852","article-title":"Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome","volume":"131","author":"Weiss","year":"2018","journal-title":"Blood"},{"key":"10.1136\/ard-2024-225853_bib58","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/rheumatology\/keq133","article-title":"Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of Interleukin-18 in its pathogenesis","volume":"49","author":"Shimizu","year":"2010","journal-title":"Rheumatology"},{"key":"10.1136\/ard-2024-225853_bib59","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/cei.13543","article-title":"The role of Interleukin-18 in the diagnosis and monitoring of hemophagocytic lymphohistiocytosis\/macrophage activation syndrome \u2013 a systematic review","volume":"203","author":"Krei","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard-2024-225853_bib60","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/annrheumdis-2015-209020","article-title":"Elevated circulating levels of interferon-\u0393 and interferon-\u0393-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"76","author":"Bracaglia","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-225853_bib61","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.cyto.2019.03.018","article-title":"Clinical significance of serum Cxcl9 levels as a biomarker for systemic juvenile idiopathic arthritis associated macrophage activation syndrome","volume":"119","author":"Mizuta","year":"2019","journal-title":"Cytokine"},{"key":"10.1136\/ard-2024-225853_bib62","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1136\/annrheumdis-2020-217007","article-title":"Total adenosine deaminase highly correlated with adenosine deaminase 2 activity in serum","volume":"81","author":"Gao","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-225853_bib63","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-10-3413","article-title":"An animal model of hemophagocytic lymphohistiocytosis (HLH): Cd8+ T cells and interferon gamma are essential for the disorder","volume":"104","author":"Jordan","year":"2004","journal-title":"Blood"},{"key":"10.1136\/ard-2024-225853_bib64","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1182\/blood.2020009499","article-title":"T-cell activation profiles distinguish hemophagocytic lymphohistiocytosis and early sepsis","volume":"137","author":"Chaturvedi","year":"2021","journal-title":"Blood"},{"key":"10.1136\/ard-2024-225853_bib65","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1007\/s10067-017-3830-3","article-title":"Macrophage activation syndrome in still's disease: analysis of clinical characteristics and survival in paediatric and adult patients","volume":"36","author":"Ruscitti","year":"2017","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard-2024-225853_bib66","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1093\/rheumatology\/keac027","article-title":"Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset still's disease","volume":"61","author":"Ruscitti","year":"2022","journal-title":"Rheumatology"},{"key":"10.1136\/ard-2024-225853_bib67","doi-asserted-by":"crossref","first-page":"787","DOI":"10.7705\/biomedica.5849","article-title":"Niveles de Ferritina en Artritis Idiop\u00e1tica Juvenil de Inicio Sist\u00e9mico Comparada con Otras Fiebres de Origen Desconocido: Estudio Multic\u00e9ntrico de Pruebas Diagn\u00f3sticas","volume":"41","author":"Eraso","year":"2021","journal-title":"Biomedica"},{"key":"10.1136\/ard-2024-225853_bib68","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1093\/rheumatology\/keab729","article-title":"Mrp8\/14 serum levels as diagnostic markers for systemic juvenile idiopathic arthritis in children with prolonged fever","volume":"61","author":"Park","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard-2024-225853_bib69","first-page":"322","article-title":"Diagnostic value of ferritin and glycosylated ferritin in adult onset still's disease","volume":"28","author":"Fautrel","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2024-225853_bib70","doi-asserted-by":"crossref","first-page":"e2307","DOI":"10.6061\/clinics\/2021\/e2307","article-title":"The role of platelet to mean platelet volume ratio in the identification of adult-onset still's disease from sepsis","volume":"76","author":"Ge","year":"2021","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1136\/ard-2024-225853_bib71","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3899\/jrheum.120079","article-title":"Serum S100A8\/A9, but not follistatin-like protein 1 and interleukin 18, may be a useful biomarker of disease activity in adult-onset still's disease","volume":"39","author":"Kim","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2024-225853_bib72","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1080\/14397595.2017.1422231","article-title":"Beneficial use of serum ferritin and heme oxygenase-1 as biomarkers in adult-onset still's disease: a multicenter retrospective study","volume":"28","author":"Kirino","year":"2018","journal-title":"Mod Rheumatol"},{"key":"10.1136\/ard-2024-225853_bib73","first-page":"274","article-title":"Platelet parameters aid identification of adult-onset still's disease from sepsis","volume":"77","author":"Liu","year":"2019","journal-title":"Neth J Med"},{"key":"10.1136\/ard-2024-225853_bib74","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1590\/1806-9282.20210649","article-title":"Role of mean platelet volume in differential diagnosis of adult-onset still's disease and sepsis","volume":"67","author":"Luo","year":"2021","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"10.1136\/ard-2024-225853_bib75","doi-asserted-by":"crossref","first-page":"e30152","DOI":"10.1097\/MD.0000000000030152","article-title":"Diagnostic utility of clinical characteristics, laboratory tests, and serum Ferritin in diagnosis of adult-onset still disease","volume":"101","author":"Sagy","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"10.1136\/ard-2024-225853_bib76","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12865-022-00477-5","article-title":"Increased serum adenosine deaminase activity in patients with adult-onset still's disease","volume":"23","author":"Xu","year":"2022","journal-title":"BMC Immunol"},{"key":"10.1136\/ard-2024-225853_bib77","doi-asserted-by":"crossref","first-page":"5012","DOI":"10.3390\/jcm11175012","article-title":"Evaluation of glycosylated ferritin in adult-onset still's disease and differential diagnoses","volume":"11","author":"Guerber","year":"2022","journal-title":"J Clin Med"},{"key":"10.1136\/ard-2024-225853_bib78","doi-asserted-by":"crossref","first-page":"e5958","DOI":"10.1590\/1414-431x20165958","article-title":"Extremely elevated IL-18 levels may help distinguish systemic-onset juvenile idiopathic arthritis from other febrile diseases","volume":"50","author":"Xia","year":"2017","journal-title":"Braz J Med Biol Res"},{"key":"10.1136\/ard-2024-225853_bib79","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12969-020-0398-2","article-title":"The use of S100 proteins testing in juvenile idiopathic arthritis and autoinflammatory diseases in a pediatric clinical setting: a retrospective analysis","volume":"18","author":"Aljaberi","year":"2020","journal-title":"Pediatr Rheumatol"},{"key":"10.1136\/ard-2024-225853_bib80","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/art.24349","article-title":"The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and Interleukin-1\u0392 form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis","volume":"60","author":"Frosch","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2024-225853_bib81","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10067-015-3108-6","article-title":"Serum calprotectin\u2014a promising diagnostic marker for adult-onset still's disease","volume":"35","author":"Guo","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard-2024-225853_bib82","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1002\/art.24137","article-title":"S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin","volume":"58","author":"Wittkowski","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2024-225853_bib83","doi-asserted-by":"crossref","first-page":"719544","DOI":"10.3389\/fimmu.2021.719544","article-title":"Interleukin-18 is a potential biomarker to discriminate active adult-onset still's disease from COVID-19","volume":"12","author":"Chen","year":"2021","journal-title":"Front Immunol"},{"key":"10.1136\/ard-2024-225853_bib84","first-page":"156890","article-title":"IL-18 serum level in adult onset still's disease: a marker of disease activity","author":"Colafrancesco","year":"2012","journal-title":"Int J Inflam"},{"key":"10.1136\/ard-2024-225853_bib85","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13075-020-02200-4","article-title":"Interleukin-18 and fibroblast growth factor 2 in combination is a useful diagnostic biomarker to distinguish adult-onset still's disease from sepsis","volume":"22","author":"Koga","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard-2024-225853_bib86","first-page":"703","article-title":"Diagnostic significance of serum Interleukin-18 level in adult-onset still's disease","volume":"62","author":"Maruyama","year":"2010","journal-title":"Arthritis and Rheumatism"},{"key":"10.1136\/ard-2024-225853_bib87","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.3899\/jrheum.130575","article-title":"Interleukin 18: a biomarker for differential diagnosis between adult-onset still's disease and sepsis","volume":"41","author":"Priori","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2024-225853_bib88","doi-asserted-by":"crossref","first-page":"750114","DOI":"10.3389\/fimmu.2021.750114","article-title":"Usefulness of Interleukin-18 as a diagnostic biomarker to differentiate adult-onset still's disease with\/without macrophage activation syndrome from other secondary hemophagocytic lymphohistiocytosis in adults","volume":"12","author":"Shiga","year":"2021","journal-title":"Front Immunol"},{"key":"10.1136\/ard-2024-225853_bib89","doi-asserted-by":"crossref","first-page":"155642","DOI":"10.1016\/j.cyto.2021.155642","article-title":"Biomarker screening and validation for the differentiation of bloodstream infection from adult-onset still's disease: a prospective cohort study","volume":"146","author":"Zhang","year":"2021","journal-title":"Cytokine"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724665751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724665751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard-2024-225853","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T03:52:24Z","timestamp":1739505144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724665751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":89,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0003496724665751"],"URL":"https:\/\/doi.org\/10.1136\/ard-2024-225853","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic juvenile idiopathic arthritis and adult-onset Still's disease are the same disease: evidence from systematic reviews and meta-analyses informing the 2023 EULAR\/PReS recommendations for the diagnosis and management of Still's disease","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard-2024-225853","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 \u00a9 European Alliance of Associations for Rheumatology, EULAR 2024. Re-use permitted under CC BY-NC-ND. No commercial re-use. No derivatives. See rights and permissions. Published by Elsevier Inc on behalf of EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}